Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

DENTIPATCH

LIDOCAINE

Standard Dose
46.1MG/PATCH
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DENTIPATCH is listed in Drugs@FDA under application 020575 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient LIDOCAINE Form and strength PATCH;TOPICAL - 46.1MG/PATCH Sponsor NOVEN Submission history Latest submission status date: 2001-10-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview DENTIPATCH is listed in Drugs@FDA under application 020575 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LIDOCAINE Form and strength PATCH;TOPICAL - 46.1MG/PATCH Sponsor NOVEN Submission history Latest submission status date: 2001-10-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.